This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 May;7(3):189-90.

doi: 10.1007/s11910-007-0029-z.

Anaplastic oligodendroglioma

PMID: 17488583
DOI: 10.1007/s11910-007-0029-z

Comment

Anaplastic oligodendroglioma

Lauren E Abrey. Curr Neurol Neurosci Rep. 2007 May.

. 2007 May;7(3):189-90.

doi: 10.1007/s11910-007-0029-z.

Author

PMID: 17488583
DOI: 10.1007/s11910-007-0029-z

No abstract available

PubMed Disclaimer

Comment on

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
Intergroup Radiation Therapy Oncology Group Trial 9402; Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W. Intergroup Radiation Therapy Oncology Group Trial 9402, et al. J Clin Oncol. 2006 Jun 20;24(18):2707-14. doi: 10.1200/JCO.2005.04.3414. J Clin Oncol. 2006. PMID: 16782910 Clinical Trial.
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allgeier A, Lacombe D, Gorlia T. van den Bent MJ, et al. J Clin Oncol. 2006 Jun 20;24(18):2715-22. doi: 10.1200/JCO.2005.04.6078. J Clin Oncol. 2006. PMID: 16782911 Clinical Trial.

Similar articles

[IDH、TERT and 1p/19q predicting clinical outcomes in patients with anaplastic oligodendroglioma].
Ji YC, Zhan YB, Liu XZ, Zhang ZY. Ji YC, et al. Zhonghua Yi Xue Za Zhi. 2019 Jul 2;99(25):1959-1962. doi: 10.3760/cma.j.issn.0376-2491.2019.25.011. Zhonghua Yi Xue Za Zhi. 2019. PMID: 31269600 Chinese.
Anaplastic astrocytoma and anaplastic oligodendroglioma occurring 6 years after subtotal resection of a central neurocytoma. Case report.
Kanamori M, Kumabe T, Watanabe M, Tominaga T. Kanamori M, et al. J Neurosurg. 2007 Jul;107(1):185-9. doi: 10.3171/JNS-07/07/0185. J Neurosurg. 2007. PMID: 17639893
Bony metastases of anaplastic oligodendroglioma respond to temozolomide.
Morrison T, Bilbao JM, Yang G, Perry JR. Morrison T, et al. Can J Neurol Sci. 2004 Feb;31(1):102-8. doi: 10.1017/s0317167100002912. Can J Neurol Sci. 2004. PMID: 15038479 Review.
The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.
Smith SF, Simpson JM, Brewer JA, Sekhon LH, Biggs MT, Cook RJ, Little NS. Smith SF, et al. J Neurooncol. 2006 Oct;80(1):75-82. doi: 10.1007/s11060-006-9158-5. Epub 2006 Jun 23. J Neurooncol. 2006. PMID: 16794749
Anaplastic intraventricular oligodendroglioma: case report and review of the literature.
Zada G, McNatt SA, Gonzalez-Gomez I, McComb JG. Zada G, et al. Surg Neurol. 2009 Jun;71(6):693-700. doi: 10.1016/j.surneu.2007.11.013. Epub 2008 Mar 4. Surg Neurol. 2009. PMID: 18291495 Review.

See all similar articles

References

1. J Clin Oncol. 2003 Jul 1;21(13):2525-8 - PubMed
1. N Engl J Med. 2005 Mar 10;352(10 ):987-96 - PubMed
1. J Clin Oncol. 2006 Jun 20;24(18):2689-90 - PubMed
1. J Clin Oncol. 1994 Oct;12(10):2013-21 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.